





significance was set at p < 0.05.
A total of 2,247 samples
were received during the study
period. Of the 1,242 bacteria
isolated, 502 (40.4%) were
, 232
(18.7%) were and
146 (11.8%) were Streptococcus
species: 78 were isolated from
blood, 9 from sputum, 11 from
throat swabs and 28 from other sites
while urine and eye swabs had 10
each. One hundred and six (72.6%)
of the streptococci were from
children aged 5 years and below.
Most of the Streptococci (88.1%)
were untyped. Among the 17
Streptococcal isolates typed, 10
were
a n d t h r e e w e r e g r o u p B
Streptococcus.
S t r e p t o c o c c a l
infections remain an important
cause of severe disease in children
in Nigeria. The use of effective, safe
and affordable vaccine could
significantly reduce morbidity from
these infections, thus suggesting the
need for more studies to conclude
o n s t r e p t o c o c c a l v a c c i n e
deployment.
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M a t e r i a l s a n d M e t h o d s :
Streptococcus species are among
the commonest bacterial causes
of childhood morbidity in
developing countries.
Streptococcal diseases in children
have not been as well
characterized in Nigeria as it has
been in industrialized countries.
The rudimentary nature of public
health surveillance makes the true
epidemiology of the disease
difficult to ascertain. The
predominance of
in the causation of
invasive diseases has led to the
advocacy of inclusion of
pneumococcal vaccine in the
National Programme on
Immunization. However, local
data critical to inform on vaccine
deployment are scarce, thus the
need for the present study.
To study the rate of
isolation of Streptococcus species
from children aged zero to 15
years, with suspected bacterial
infections.
Laboratory records of results of
bacteriological studies of samples
from children with suspected
bacterial infections in University
of Abuja Teaching Hospital from
January 2008 through December,
2010 were retrieved and analyzed
for bacterial growth. Data analysis
Introduction
The genus Streptococcus comprises of more than 30
species. , group A
Streptococcus and group B Streptococcus are the
most common causes of human streptococcal
infections. These organisms are among the
commonest bacterial causes of childhood morbidity
Streptococcus pneumoniae
1
in developing countries like Nigeria. The
predominance of in the
causation of invasive diseases has lead to the
advocacy of inclusion of pneumococcal vaccine in
the National Programme on Immunization.
However, there is paucity of data in Nigeria on the
burden of streptococcal infections in children thus
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Statistical analysis
Results
Statistical analysis was done using Epi Info software
version 3.5.1(CDC, Atlanta, GA, USA, 2008).
Frequency tables were generated while Chi square
and Fischer's exact tests were used to test associations
between categorical variables. Statistically
significant difference level was set at p < 0.05.
A total of 2,247 samples were received during the
study period, of which 918 were blood samples, 400
were urine, 292 were stool, 226 were cerebrospinal
fluid, 19 were sputum, 344 were swabs from various
body sites, 43 were aspirates while 5 specimens were
not properly labeled to reveal their site of origin. Of
the 1,247 (55.5%) specimens that yielded growths,
1,234 yielded 1,242 bacteria while 13 yielded 13
candida species. Bacterial growth in 1226 samples
was monomicrobial while 8 samples yielded
polymicrobial growths. The rate of bacterial yield
from the various samples is thus: blood - 62.6%, urine
- 45.5%, stool - 43.5%, cerebrospinal fliud - 8.4%,
swabs from various sites - 72.1%. Of the 1,242
bacteria isolated, 502 (40.4%) were
, 232 (18.7%) were and 146
(11.8%) were Streptococcus species. Table 1.
Table 2 shows the rate of isolation of Streptococcus
species from the various samples analyzed. About
76.0% of isolates from throat swabs were
Streptococcus species while 36.8% of organisms
recovered from the cerebrospinal fluid, 36.0% of
bacteria cultured from the sputum, 20.8% of the eye
swabs isolates, 13.6% of isolates from blood and
8.3% of those recovered the ear swabs were equally
Streptococcus species. Similarly, a higher proportion
of the Streptococcus species (72.6%) were recovered
from samples taken from children aged 5 years
(Figure1).
Analysis of the contribution of Streptococcus species
to infections in children is compared with those of
other bacterial pathogens on Table 3, which show that
Streptococcus organisms is more associated with
respiratory tract infections, subarachnoid space
infections and blood stream infections Majority of
the Streptococcus species isolated (88.1%) were not
further characterized, however,
accounts for 7.5% (10), group B beta
haemolytic Streptococcus was 2.2% (3) while
anaerobic Streptococcus was 4(3.0%). Four cases of
were isolated from the
sputum, three from throat swab and one each from the







It is hopeful that data generated from this study may
offer ample evidence for the need for streptococcal
vaccine inclusion in national immunization
programmes.
To study the rate of isolation of Streptococcus
species from children aged zero to 15 years, with
suspected bacterial infections.
The study was retrospective, on bacteriological
samples from children aged 15 years and below that
were evaluated for suspected bacterial infections at
the Paediatric Department of University of Abuja
Teaching Hospital, Gwagwalada, Abuja. The
hospital is a tertiary institution at the centre of
Nigeria and serves as a major paediatric referral
centre for communities in the Federal Capital
Territory and those of the neighbouring states in
North central Nigeria.
Samples for bacteriological studies were processed
as recommended by Cheesbough et al. For blood
culture, 2 ml of venous blood was collected
aseptically after thorough skin preparation with 70%
alcohol. The blood samples were introduced into
thioglycollate broth through a sterile needle in the
ratio of one part of blood to five parts of the broth and
incubated at 37 C for seven days. The cultures were
examined daily for evidence of bacterial growth such
as turbidity, clot and gas formation. In samples that
showed such evidence, sub-cultures onto chocolate
and blood agar plates were performed and incubated
at same temperature for 24 to 72 hours. Organisms
isolated were identified by conventional methods.
Smears of swabs of eye, ear, umbilical and vaginal
discharges as well as those of wound and skin swabs,
cerebrospinal fluid and urine samples, were
inoculated on MacConkey, chocolate and blood agar
plates and incubated for 24 to 48 hours and the
bacteria grown were identified using standard
methods.
Bacteriological results between 1 January 2008 and
31 December, 2010 were collated and analyzed to











Table 1: Distribution of isolates based on the site of isolation






















311 64 3 6 24 27 16 17 4 30 502(40.4)
Streptococcus
species
78 10 1 7 10 9 9 4 11 7 146(11.8)
Escherichia coli 55 55 89 1 3 10 - 9 1 9 232(18.7)


























TOTAL 575 182 127 19 47 11
1
29 49 18 78
Others refer to aspirates from joint space, pleural cavity, gastric contents, peritoneal fluid (ascites), pus and










Blood (n = 918) 575(62.6) 78 (8.5) 13.6
Stool (n = 296) 127(43.5) 1(0.3) 0.8
Urine (n = 400) 182(45.5) 10 (2.5) 5.5
Cerebrospinal fluid (n = 226) 19(8.4) 7 (3.1) 36.8
Eye swabs (n = 66) 48(72.7) 10 (15.2) 20.8
Ear swabs (n = 129) 111(86.1) 9 (7.0) 8.3
Wound swabs (n = 57) 49(85.9) 4 (7.0) 9.5
Throat swabs (n = 19) 18(94.7) 11 (57.9) 75.9
Sputum (n = 39) 29(74.4) 9 (23.1) 36.0
Aspirates+ (n = 43) 25(58.1) 4 (9.3) 16.0
Skin swabs (n = 21) 11(52.4) - -
Vaginal swabs (n = 21) 11(52.4) 2 (9.5) 18.2
Umbilical swabs (n = 8) 8(100.0) - -
Miscellaneous** (n = 5) 3(60.0) 1 (20.0) 33.3
Table 2: Rate of isolation of Streptococcus species from laboratory samples with positive bacterial growth.
** Miscellaneous = Site of specimen collection was not stated in 5 of the analyzed samples.
+ refer to aspirates from joint space, pleural cavity, gastric contents, peritoneal fluid (ascites) and abscesses.
Figure 1: Proportion of Streptococcus















Table 3: Comparison of the contribution of Streptococcus species to those of other commonly isolated
bacteria in the causation of infection** in children.













78 7 9 20 32
Staph
(n=502)
311 6 27 20 138
χ2 3.68 FET 0.03 16.79 1.52
P 0.0791 0.0125 0.8732 <0.0001 0.2149
Strep
(n=146)
78 7 9 20 32
E. coli
(n=232)
55 1 11 1 164
χ2 33.41 FET 0.13 27.59 83.44
P <0.0001 0.0063 0.7145 <0.0001 <0.0001
Strep
(n=146)
78 7 9 20 32
Klebsiella
(n=140)
46 3 12 6 73
χ2 11.49 FET 0.31 6.57 26.81
P 0.0007 0.0501 0.5799 0.0104 <0.0001
CSF = Cerebrospinal fluid; Resp tract = Respiratory tract; Staph = ; Strep =
Streptococcus species; E. coli =
** Isolation of bacteria from specimens taken from stated body sites is considered as infection of that site
+Others refer to isolates from stool, urine, eye, ear, wound and aspirates from joint space, pleural cavity,
gastric contents, peritoneal fluid (ascites), pus and discharges from umbilicus, vaginal as well as swabs of




of Onipede from Ile-Ife, South western Nigeria
and Nwadioha from Kano, North western
Nigeria. Differences in methodology may account
for this; whereas the report from Ile-Ife considered
only patients with deep seated infections, the present
study included superficial infections. Similarly, the
report from Kano, which revealed isolation of only
ten cases of from 3840
blood culture samples, also excluded results of
bacteriological studies of swabs of body discharges as
well as urine, cerebrospinal fluid and stool specimens.
Reports are however consistent on the role of
streptococcal organisms in invasive diseases.
The high isolation rate of streptococcus species from
the cerebrospinal fluid, sputum, throat swabs and
blood specimens from children with suspected
bacterial meningitis, pneumonia, pharyngitis and
septicaemia in the present study is a pointer to the
magnitude of invasive streptococcal infections in the
area of study and suggests the need for preventive









Streptococcal organisms are common bacterial
agents causing childhood morbidity and mortality.
Almost all organ systems could be affected by these
agents and there are indications that the incidence of
infections with these agents may be increasing. The
overall prevalence of streptococcal infections in the
present study is 11.8%. However, with further
categorization, 75.9% of isolates from throat swabs,
36.8% of organisms recovered from the
cerebrospinal fluid and 36.0% of bacteria cultured
from the sputum were Streptococcus species.
The high isolation rate of streptococcus species from
the cerebrospinal fluid, sputum, throat swabs and
blood in the present study corroborates the findings
of other researchers and emphasizes the role of
streptococcal organisms in systemic infections in
children. Although, the 11.8% streptococcal
infections prevalence rate in this study is lower than
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Although groupAand group B streptococcal vaccines
are at various stages of development, pneumococcal
vaccine has been licensed for use in children and have
been shown to be associated with a 98% reduction in
rates of bacteraemia and meningitis and a 67%
reduction in rates of otitis media due to vaccine
serotypes. Since it was marketed in 2000,
widespread use of this vaccine in developed countries
has caused a dramatic decline in the incidence of
invasive pneumococcal disease among infants and
children.
The high cost of conjugate pneumococcal vaccine
(approx US $50 per dose) and the challenges of
developing effective and safe vaccines against group
A and group B streptococci makes it unaffordable for
all but the wealthiest of countries, thus for low-
income countries to introduce such vaccines, there
has to be a strong political commitment. Going by the
burden of streptococcal infections in the present
study, under-five morbidity is unlikely to reduce
significantly without concerted efforts at the control
of streptococcal infections; hence introducing
vaccines against streptococcus species, though
expensive, may be lifesaving and cost-effective.
Further studies are therefore recommended on disease
burden and the cost implication of streptococcal
vaccines in developing countries.
The contribution of streptococcal infections to
morbidity in children is enormous. Introduction of
effective, safe and affordable streptococcal vaccine
could significantly alter the current pattern of






untoward effects of invasive streptococcal
Infections. Although retrospective analysis of
bacteriological samples may not be the best indicator
of the burden of bacterial infections in a community,
they nevertheless, give a clue to the magnitude of
morbidity caused by pathogenic organisms and the
distribution of the various agents among susceptible
individuals. In resource-limited countries,
retrospective analysis may be the main source of
aetiological information as bacteriological data from
community settings are not readily available due to
lack of laboratory and culture facilities in most
primary and secondary health facilities.
From the result of the present study, one may
speculate that the control of streptococcal infections
in children may drastically reduce the burden of
bacterial meningitis, bacterial pneumonia, bacterial
pharyngitis, septicaemia and possibly, the
postinfectious syndromes of acute rheumatic fever
and glomerulonephritis.
The experience over the years, of national
immunization programs, demonstrates that
immunization is one of the effective public health
strategies. Rapid deployment and use of traditional
vaccines against childhood killer diseases have been
the most important contributors to reductions in child
mortality and increased life expectancy in
developing countries. However, introducing new
vaccines into the National Program on Immunization
requires enormous human and financial resources
including engagement of national leaders
responsible for primary health care services and
presenting them with evidence on the burden of the
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